Effect of lesion dimension on survival in patients with T1a renal cell carcinoma who underwent deferred surgery

被引:0
作者
Wang, Lin [1 ]
Huang, Long [1 ]
Lei, Lei [1 ]
Xu, Yan [1 ]
Huang, Lijuan [1 ]
Liu, Hong [1 ]
Wang, Haiyan [1 ]
Liu, Dongliang [1 ]
机构
[1] 363 Hosp, Dept Urol, Chengdu 610041, Peoples R China
关键词
Small renal mass (SRM); Renal cell carcinoma (RCC); Active surveillance (AS); Nephrectomy; Overall survival (OS); KIDNEY CANCER; SURVEILLANCE; MASSES; MANAGEMENT; RATES;
D O I
10.1007/s11255-024-04041-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Small renal masses (SRMs) have been shown to have low malignant potential. Active surveillance (AS), typically characterized by regular follow-up and delayed nephrectomy if necessary, is recommended as an option for frail patients with SRMs. Nevertheless, the impact of tumor size on survival in T1a RCC patients undergoing delayed nephrectomy for SRMs remains unclear. Methods Patients diagnosed with non-metastatic T1a RCC who underwent nephrectomy were identified from the Surveillance, Epidemiology, and End Results (SEER) database and divided into immediate (< 6 months) and delayed nephrectomy (>= 6 months) groups based on the duration from diagnosis to nephrectomy. After propensity score matching (PSM), overall survival (OS) and cancer-specific survival (CSS) were estimated by K-M curves and compared with log-rank test. Results A total of 27,502 patients were enrolled, of whom 26,915 (97.9%) received immediate nephrectomy and 587 (2.1%) received delayed nephrectomy. After PSM, 1174 patients who underwent immediate nephrectomy and 587 patients who underwent delayed nephrectomy were included. With a median delay of 7 months, delayed nephrectomy resulted in non-inferior OS for RCC tumors sized 0.1-2.0 cm (HR = 1.12, p = 0.636). However, for RCC tumors sized 2.1-3.0 cm (HR = 1.60, p = 0.008) and 3.1-4.0 cm (HR = 1.89, p < 0.001), delayed nephrectomy showed inferior OS compared to immediate nephrectomy. Delayed nephrectomy did not result in significantly worse CSS than immediate nephrectomy in all tumor size subgroups (all p > 0.05), however this may be due to sample size limiting statistical power. Conclusion Based on the SEER database, we found that with a median delay of 7 months, 2 cm may be an appropriate cut-off point of delayed nephrectomy for patients diagnosed with non-metastatic T1a RCC.
引用
收藏
页码:2913 / 2921
页数:9
相关论文
共 20 条
  • [1] The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
    Amin, Mahul B.
    Greene, Frederick L.
    Edge, Stephen B.
    Compton, Carolyn C.
    Gershenwald, Jeffrey E.
    Brookland, Robert K.
    Meyer, Laura
    Gress, Donna M.
    Byrd, David R.
    Winchester, David P.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 93 - 99
  • [2] Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
    Campbell, Steven C.
    Clark, Peter E.
    Chang, Sam S.
    Karam, Jose A.
    Souter, Lesley
    Uzzo, Robert G.
    [J]. JOURNAL OF UROLOGY, 2021, 206 (02) : 199 - 208
  • [3] A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
    Capitanio, Umberto
    Bedke, Jens
    Albiges, Laurence
    Volpe, Alessandro
    Giles, Rachel H.
    Hora, Milan
    Marconi, Lorenzo
    Klatte, Tobias
    Abu-Ghanem, Yasmin
    Dabestani, Saeed
    Pello, Sergio Fernandez
    Hofmann, Fabian
    Kuusk, Teele
    Tahbaz, Rana
    Powles, Thomas
    Ljungberg, Borje
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2023, 83 (01) : 3 - 5
  • [4] Rising incidence of renal cell cancer in the United States
    Chow, WH
    Devesa, SS
    Warren, JL
    Fraumeni, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1628 - 1631
  • [5] Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort
    Finelli, Antonio
    Cheung, Douglas C.
    Al-Matar, Ashraf
    Evans, Andrew J.
    Morash, Christopher G.
    Pautler, Stephen E.
    Siemens, D. Robert
    Tanguay, Simon
    Rendon, Ricardo A.
    Gleave, Martin E.
    Drachenberg, Darrel E.
    Chin, Joseph L.
    Fleshner, Neil E.
    Haider, Masoom A.
    Kachura, John R.
    Sykes, Jenna
    Jewett, Michael A. S.
    [J]. EUROPEAN UROLOGY, 2020, 78 (03) : 460 - 467
  • [6] Huang WC., 2013, J UROLOGY, V189, DOI [10.1016/j.juro.2013.02.2537, DOI 10.1016/J.JURO.2013.02.2537]
  • [7] PARTIAL NEPHRECTOMY VS. NON-SURGICAL MANAGEMENT FOR SMALL RENAL MASSES: A POPULATION-BASED COMPARISON OF DISEASE-SPECIFIC AND OVERALL SURVIVAL
    Hyams, Elias S.
    Pierorazio, Phillip M.
    Mullins, Jeffrey K.
    Clemens, Gwendolyn
    Thompson, Carol B.
    Allaf, Mohamad E.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04) : E678 - E678
  • [8] Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer
    Jewett, Michael A. S.
    Mattar, Kamal
    Basiuk, Joan
    Morash, Christopher G.
    Pautler, Stephen E.
    Siemens, D. Robert
    Tanguay, Simon
    Rendon, Ricardo A.
    Gleave, Martin E.
    Drachenberg, Darrel E.
    Chow, Raymond
    Chung, Hannah
    Chin, Joseph L.
    Fleshner, Neil E.
    Evans, Andrew J.
    Gallie, Brenda L.
    Haider, Masoom A.
    Kachura, John R.
    Kurban, Ghada
    Fernandes, Kimberly
    Finelli, Antonio
    [J]. EUROPEAN UROLOGY, 2011, 60 (01) : 39 - 44
  • [9] Renal cell cancer stage migration - Analysis of the National Cancer Data Base
    Kane, Christopher J.
    Mallin, Katherine
    Ritchey, Jamie
    Cooperberg, Matthew R.
    Carroll, Peter R.
    [J]. CANCER, 2008, 113 (01) : 78 - 83
  • [10] European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
    Ljungberg, Borje
    Albiges, Laurence
    Abu-Ghanem, Yasmin
    Bedke, Jens
    Capitanio, Umberto
    Dabestani, Saeed
    Fernandez-Pello, Sergio
    Giles, Rachel H.
    Hofmann, Fabian
    Hora, Milan
    Klatte, Tobias
    Kuusk, Teele
    Lam, Thomas B.
    Marconi, Lorenzo
    Powles, Thomas
    Tahbaz, Rana
    Volpe, Alessandro
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2022, 82 (04) : 399 - 410